Sunzen Group Berhad (KLSE:SUNZEN)
Malaysia · Delayed Price · Currency is MYR 0.2250
0.00 (0.00%)
At close: Sep 17, 2026
Sunzen Group Berhad Financials Overview
Financials in millions MYR. Fiscal year is July - June.
Millions MYR. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Revenue Revenue Growth | 93.51 | 93.51 | 80.58 | 95.12 | 98.13 | 97.09 |
Revenue Growth | 16.05% | 16.05% | -15.28% | -3.07% | 1.07% | 7.31% |
Gross Profit Gross Profit Growth | 35.13 | 35.13 | 25 | 25.55 | 30.58 | 23.93 |
Operating Income Operating Income Growth | 16.65 | 16.65 | 4.28 | 11.09 | 12.22 | 7.81 |
Net Income Net Income Growth | 10.29 | 10.29 | 2.59 | 6.03 | 6.8 | 3.75 |
Earnings Per Share EPS Growth | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 | 0.00 |
EPS Growth | 332.30% | 332.30% | -61.83% | -17.61% | 89.40% | 327.18% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Human Health Human Health Growth | 63.86 | 63.86 | 57.07 | 76.53 | 80.3 | 81.75 |
Medical Devices and Services Medical Devices and Services Growth | 9.83 | 9.83 | - | - | - | - |
Loan financing Loan financing Growth | 19.83 | 19.83 | 13.74 | 13.1 | 13.05 | 9.51 |
Eliminations Eliminations Growth | - | - | -1.46 | -1.92 | - | -4.7 |
Manufacturing and Trading of Animal Health Products Manufacturing and Trading of Animal Health Products Growth | - | - | 4.27 | 7.41 | 4.78 | 10.53 |
Pharmaceutical and Medical Goods Pharmaceutical and Medical Goods Growth | - | - | 6.96 | - | - | - |
Total Total Growth | 93.51 | 93.51 | 80.58 | 95.12 | 98.13 | 97.09 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Investments Cash & Investments Growth | 21.83 | 21.83 | 18.59 | 27.6 | 22.98 | 12.13 |
Total Debt Total Debt Growth | 21.2 | 21.2 | 19.89 | 7.66 | 7.83 | 5.14 |
Net Cash (Debt) Net Cash Growth | 0.63 | 0.63 | -1.3 | 19.94 | 15.15 | 6.98 |
Net Cash Growth | - | - | - | 31.61% | 116.90% | -83.36% |
Net Cash Per Share Net Cash Per Share Growth | 0.00 | 0.00 | -0.00 | 0.02 | 0.02 | 0.01 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 6.13 | 6.13 | -8.81 | 9.82 | 9.43 | -32.15 |
Capital Expenditures CapEx Growth | -1.42 | -1.42 | -3 | -0.62 | -0.57 | -2.19 |
Free Cash Flow Free Cash Flow Growth | 4.71 | 4.71 | -11.81 | 9.2 | 8.86 | -34.34 |
Free Cash Flow Growth | - | - | - | 3.86% | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Gross Margin | 37.57% | 37.57% | 31.02% | 26.86% | 31.16% | 24.64% |
Operating Margin | 17.80% | 17.80% | 5.31% | 11.66% | 12.45% | 8.05% |
Pretax Margin | 16.99% | 16.99% | 4.10% | 11.11% | 11.99% | 7.69% |
Profit Margin | 11.01% | 11.01% | 3.21% | 6.33% | 6.93% | 3.86% |
FCF Margin | 5.04% | 5.04% | -14.66% | 9.67% | 9.03% | -35.37% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 21, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.004 | - | - | - | - | - |
Dividend Per Share Growth | 0% | - | - | - | - | - |
Dividend Yield | 1.78% | - | - | - | - | - |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 21, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
PE Ratio | 18.60 | 19.34 | 87.95 | 41.38 | 31.11 | 37.59 |
P/FCF Ratio | 37.93 | 42.25 | - | 27.10 | 23.87 | - |
PS Ratio | 1.91 | 2.13 | 2.82 | 2.62 | 2.15 | 1.45 |